394 related articles for article (PubMed ID: 30229376)
41. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
[TBL] [Abstract][Full Text] [Related]
42. Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group.
Nestler-Parr S; Korchagina D; Toumi M; Pashos CL; Blanchette C; Molsen E; Morel T; Simoens S; Kaló Z; Gatermann R; Redekop W
Value Health; 2018 May; 21(5):493-500. PubMed ID: 29753344
[TBL] [Abstract][Full Text] [Related]
43. Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions.
Wong CKH; Wu O; Cheung BMY
Appl Health Econ Health Policy; 2018 Feb; 16(1):5-14. PubMed ID: 28702874
[TBL] [Abstract][Full Text] [Related]
44. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
[TBL] [Abstract][Full Text] [Related]
45. The Value of Medicines: A Crucial but Vague Concept.
Antoñanzas F; Terkola R; Postma M
Pharmacoeconomics; 2016 Dec; 34(12):1227-1239. PubMed ID: 27444306
[TBL] [Abstract][Full Text] [Related]
46. PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION.
Tordrup D; Chouaid C; Cuijpers P; Dab W; van Dongen JM; Espin J; Jönsson B; Léonard C; McDaid D; McKee M; Miguel JP; Patel A; Reginster JY; Ricciardi W; Rutten-van Molken M; Rupel VP; Sach T; Sassi F; Waugh N; Bertollini R
Int J Technol Assess Health Care; 2017 Jan; 33(6):609-619. PubMed ID: 29081308
[TBL] [Abstract][Full Text] [Related]
47. Evidence, values, and decision making.
Rawlins MD
Int J Technol Assess Health Care; 2014 Apr; 30(2):233-8. PubMed ID: 24774475
[TBL] [Abstract][Full Text] [Related]
48. The application of economics concepts to stratified medicine--use of health economics data to support market access for stratified medicine interventions.
Fugel HJ; Nuijten M; Faulkner E
J Med Econ; 2014 May; 17(5):305-11. PubMed ID: 24654841
[TBL] [Abstract][Full Text] [Related]
49. Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion.
Horgan D; Metspalu A; Ouillade MC; Athanasiou D; Pasi J; Adjali O; Harrison P; Hermans C; Codacci-Pisanelli G; Koeva J; Szucs T; Cursaru V; Belina I; Bernini C; Zhuang S; McMahon S; Toncheva D; Thum T
Biomed Hub; 2020; 5(3):130-152. PubMed ID: 33987187
[TBL] [Abstract][Full Text] [Related]
50. INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES.
Martelli N; Billaux M; Borget I; Pineau J; Prognon P; van den Brink H
Int J Technol Assess Health Care; 2015 Jan; 31(1-2):12-8. PubMed ID: 25991072
[TBL] [Abstract][Full Text] [Related]
51. Can we reliably benchmark health technology assessment organizations?
Drummond M; Neumann P; Jönsson B; Luce B; Schwartz JS; Siebert U; Sullivan SD
Int J Technol Assess Health Care; 2012 Apr; 28(2):159-65. PubMed ID: 22559758
[TBL] [Abstract][Full Text] [Related]
52. Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3].
Lakdawalla DN; Doshi JA; Garrison LP; Phelps CE; Basu A; Danzon PM
Value Health; 2018 Feb; 21(2):131-139. PubMed ID: 29477390
[TBL] [Abstract][Full Text] [Related]
53. Evidence-based decision-making 3: Health technology assessment.
O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
[TBL] [Abstract][Full Text] [Related]
54. Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group.
Garfield S; Polisena J; S Spinner D; Postulka A; Y Lu C; Tiwana SK; Faulkner E; Poulios N; Zah V; Longacre M
Value Health; 2016; 19(5):577-87. PubMed ID: 27565275
[TBL] [Abstract][Full Text] [Related]
55. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
56. Challenges and opportunities for access to Advanced Therapy Medicinal Products in Brazil.
Sachetti CG; Barbosa A; de Carvalho ACC; Araujo DV; da Silva EN
Cytotherapy; 2024 Mar; ():. PubMed ID: 38639672
[TBL] [Abstract][Full Text] [Related]
57. The advanced therapy classification procedure. Overview of experience gained so far.
Voltz-Girolt C; Celis P; Boucaumont M; D'Apote L; Pinheiro MH; Papaluca-Amati M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):811-5. PubMed ID: 21698533
[TBL] [Abstract][Full Text] [Related]
58. HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL, EASTERN, AND SOUTH EUROPEAN COUNTRIES: CROATIA.
Huic M; Tandara Hacek R; Svajger I
Int J Technol Assess Health Care; 2017 Jan; 33(3):376-383. PubMed ID: 28803589
[TBL] [Abstract][Full Text] [Related]
59. Advanced Therapy Medicinal Products Challenges and Perspectives in Regenerative Medicine.
Goula A; Gkioka V; Michalopoulos E; Katsimpoulas M; Noutsias M; Sarri EF; Stavropoulos C; Kostakis A
J Clin Med Res; 2020 Dec; 12(12):780-786. PubMed ID: 33447311
[TBL] [Abstract][Full Text] [Related]
60. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
